Company / Book Value per Share
Xenon Pharmaceuticals Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.34
FY2025
5-year range
$7.34 / $13.873
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#80 of 209
Health Care
What the data says
At $7.34, Xenon Pharmaceuticals Inc.'s book value per share ranks #80 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $3.546 in FY2019 to $13.873 in FY2023.
Based on SEC 10-K filings.
$7.34 in FY2025 with a 5-year CAGR of +8.2%.
Declined from $13.873 to $7.34 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
#80 of 209 in Health CareTop 38% of 209This company $7.34 Sector average $189.406
▼
-96.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.2%, indicating consistent growth.
- In FY2025, book value per share decreased 24.3% year-over-year.
- Ranks #80 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.34 | -24.3% |
| FY2024 | $9.691 | -30.1% |
| FY2023 | $13.873 | +16.4% |
| FY2022 | $11.917 | -5.5% |
| FY2021 | $12.607 | +154.1% |
| FY2020 | $4.961 | +39.9% |
| FY2019 | $3.546 | -38.2% |
| FY2018 | $5.739 | +61.0% |
| FY2017 | $3.564 | -19.8% |
| FY2016 | $4.442 | +3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026